• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位黑色素瘤的管理。

Managing melanoma in situ.

作者信息

Toren Kristen L, Parlette Eric C

机构信息

Department of Dermatology, Walter Reed Army Medical Center, Washington, DC, USA.

出版信息

Semin Cutan Med Surg. 2010 Dec;29(4):258-63. doi: 10.1016/j.sder.2010.10.002.

DOI:10.1016/j.sder.2010.10.002
PMID:21277539
Abstract

Melanoma is a highly aggressive skin cancer with an increasing incidence. Melanoma in situ is an early, non-invasive form in which the tumor is confined to the epidermis. Treatment of melanoma in situ is challenging due to the frequent subclinical microscopic spread and to the presentation on the head and neck in cosmetically sensitive areas with chronic sun damage. Optimizing tumor eradication is imperative to reduce the potential progression into invasive disease and metastasis, all while maintaining cosmesis. Multiple treatment regimens have been implemented for managing difficult melanoma in situ tumors. We provide a thorough review of surgical, and non-surgical, management of melanoma in situ which can pose therapeutic dilemmas due to size, anatomic location, and subclinical spread.

摘要

黑色素瘤是一种侵袭性很强的皮肤癌,发病率呈上升趋势。原位黑色素瘤是一种早期的非侵袭性形式,肿瘤局限于表皮。由于频繁的亚临床微小扩散以及在头颈部等存在慢性阳光损伤的美容敏感区域出现,原位黑色素瘤的治疗具有挑战性。优化肿瘤根除对于减少潜在进展为侵袭性疾病和转移至关重要,同时还要保持美观。已经实施了多种治疗方案来管理难处理的原位黑色素瘤肿瘤。我们对原位黑色素瘤的手术和非手术管理进行了全面综述,这些原位黑色素瘤由于大小、解剖位置和亚临床扩散可能会带来治疗难题。

相似文献

1
Managing melanoma in situ.原位黑色素瘤的管理。
Semin Cutan Med Surg. 2010 Dec;29(4):258-63. doi: 10.1016/j.sder.2010.10.002.
2
Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.原位黑素瘤的治疗选择:局部治疗和放射治疗、切除术和 Mohs 手术。
Int J Dermatol. 2010 May;49(5):482-91. doi: 10.1111/j.1365-4632.2010.04423.x.
3
Treatment of cutaneous metastatic melanoma with imiquimod 5% cream and the pulsed-dye laser.
Br J Dermatol. 2005 Feb;152(2):376-7. doi: 10.1111/j.1365-2133.2005.06307.x.
4
Melanoma in situ: Part II. Histopathology, treatment, and clinical management.原位黑素瘤:第二部分。组织病理学、治疗和临床管理。
J Am Acad Dermatol. 2015 Aug;73(2):193-203; quiz 203-4. doi: 10.1016/j.jaad.2015.03.057.
5
Successful treatment of persistent melanoma in situ with 5% imiquimod cream.5%咪喹莫特乳膏成功治疗原位持续性黑素瘤
Dermatol Surg. 2004 Dec;30(12 Pt 2):1543-5. doi: 10.1111/j.1524-4725.2004.30565.x.
6
In situ photoimmunotherapy: a tumour-directed treatment for melanoma.原位光免疫疗法:一种针对黑色素瘤的肿瘤导向治疗方法。
Br J Dermatol. 2006 Dec;155(6):1287-92. doi: 10.1111/j.1365-2133.2006.07514.x.
7
Treatment of skin malignancies.皮肤恶性肿瘤的治疗。
J Fam Pract. 2003 Jun;52(6):456-64.
8
Mohs surgery for the treatment of melanoma in situ: a review.莫氏手术治疗原位黑色素瘤:综述
Dermatol Surg. 2007 Apr;33(4):395-402. doi: 10.1111/j.1524-4725.2007.33085.x.
9
Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.局部应用5%咪喹莫特乳膏成功治疗原位恶性黑色素瘤。
Int J Dermatol. 2005 May;44(5):428-34. doi: 10.1111/j.1365-4632.2005.02582.x.
10
The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician.
Mayo Clin Proc. 2001 Dec;76(12):1253-65. doi: 10.4065/76.12.1253.

引用本文的文献

1
Donors With Previous Malignancy: When Is It Safe to Proceed With Organ Transplantation?有既往恶性肿瘤病史的供体:何时进行器官移植才安全?
Transpl Int. 2025 Jan 24;38:13716. doi: 10.3389/ti.2025.13716. eCollection 2025.
2
Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer.咪喹莫特作为局部免疫疗法在皮肤癌前病变和皮肤癌的治疗中的应用。
Int J Mol Sci. 2023 Jun 29;24(13):10835. doi: 10.3390/ijms241310835.
3
Drug-selected population in melanoma A2058 cells as melanoma stem-like cells retained angiogenic features - the potential roles of heparan-sulfate binding ANGPTL4 protein.
在黑色素瘤 A2058 细胞中药物选择的人群作为黑色素瘤干细胞样细胞保留了血管生成特征-硫酸乙酰肝素结合 ANGPTL4 蛋白的潜在作用。
Aging (Albany NY). 2020 Nov 10;12(22):22700-22718. doi: 10.18632/aging.103890.
4
Linguine technique for excision of lentigo maligna and poorly defined non-melanotic skin cancer - A case series.用于切除恶性雀斑样痣和边界不清的非黑素性皮肤癌的细面条技术——病例系列
JPRAS Open. 2019 Jan 12;19:111-117. doi: 10.1016/j.jpra.2019.01.005. eCollection 2019 Mar.
5
Enhanced chemosensitization of anoikis-resistant melanoma cells through syndecan-2 upregulation upon anchorage independency.通过在锚定非依赖性时上调syndecan-2增强对失巢凋亡抗性黑色素瘤细胞的化学增敏作用。
Oncotarget. 2017 Jun 27;8(37):61528-61537. doi: 10.18632/oncotarget.18616. eCollection 2017 Sep 22.
6
Recurrent in situ melanoma successfully treated with ingenol mebutate.复发性原位黑色素瘤经 ingenol mebutate 成功治疗。
Dermatol Ther (Heidelb). 2014 Jun;4(1):131-5. doi: 10.1007/s13555-014-0051-4. Epub 2014 Apr 2.
7
Melanoma in situ in a private practice setting 2005 through 2009: location, lesion size, lack of concern.2005 年至 2009 年私人诊所中黑色素瘤原位:位置、病变大小、缺乏关注。
J Am Acad Dermatol. 2012 Sep;67(3):e105-9. doi: 10.1016/j.jaad.2011.11.949. Epub 2012 Jan 9.